Details for New Drug Application (NDA): 089834
✉ Email this page to a colleague
NDA 089834 describes WELLCOVORIN, which is a drug marketed by Glaxosmithkline and is included in five NDAs. Additional details are available on the WELLCOVORIN profile page.
The generic ingredient in WELLCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
The generic ingredient in WELLCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
Summary for 089834
| Tradename: | WELLCOVORIN |
| Applicant: | Glaxosmithkline |
| Ingredient: | leucovorin calcium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 089834
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/VIAL | ||||
| Approval Date: | Jan 23, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
